US Stock MarketDetailed Quotes

Cognition Therapeutics (CGTX)

Watchlist
  • 1.190
  • +0.080+7.21%
Close Apr 17 16:00 ET
  • 1.180
  • -0.010-0.84%
Post 20:01 ET
106.33MMarket Cap-3.72P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cognition Therapeutics (CGTX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-29.13%24.39M
-52.25%3.67M
-49.26%5.16M
-6.72%6.87M
-5.45%8.69M
32.79%34.42M
-8.66%7.69M
44.03%10.17M
50.59%7.37M
65.68%9.19M
Selling and administrative expenses
-13.65%10.61M
-1.75%2.52M
-15.27%2.6M
-19.48%2.5M
-15.78%2.99M
-9.15%12.29M
-28.42%2.57M
-0.16%3.07M
-6.60%3.1M
0.17%3.55M
-General and administrative expense
-13.65%10.61M
-1.75%2.52M
-15.27%2.6M
-19.48%2.5M
-15.78%2.99M
-9.15%12.29M
-28.42%2.57M
-0.16%3.07M
-6.60%3.1M
0.17%3.55M
Research and development costs
-10.77%37.19M
36.71%11.15M
-66.88%3.77M
-0.83%11.48M
2.21%10.79M
12.04%41.68M
-29.71%8.15M
-2.37%11.39M
36.25%11.58M
94.35%10.55M
Other operating expenses
-19.73%-23.41M
-229.67%-10M
71.70%-1.22M
2.80%-7.11M
-3.54%-5.09M
21.19%-19.55M
55.20%-3.03M
44.13%-4.29M
-5.57%-7.31M
-43.37%-4.91M
Operating profit
29.13%-24.39M
52.25%-3.67M
49.26%-5.16M
6.72%-6.87M
5.45%-8.69M
-32.79%-34.42M
8.66%-7.69M
-44.03%-10.17M
-50.59%-7.37M
-65.68%-9.19M
Net non-operating interest income expense
48.00%-13K
0.00%-5K
0
57.14%-3K
50.00%-5K
7.41%-25K
44.44%-5K
-50.00%-3K
-16.67%-7K
0.00%-10K
Non-operating interest expense
-48.00%13K
0.00%5K
--0
-57.14%3K
-50.00%5K
-7.41%25K
-44.44%5K
50.00%3K
16.67%7K
0.00%10K
Other net income (expense)
95.12%919K
327.21%334K
-2.54%230K
-57.66%141K
336.73%214K
198.10%471K
-151.22%-147K
-24.84%236K
93.60%333K
107.97%49K
Special income (charges)
--0
--0
--0
--0
--0
---195K
--0
--0
--0
---195K
-Gain on sale of business
--0
--0
--0
--0
--0
---195K
--0
--0
--0
---195K
Other non- operating income (expenses)
37.99%919K
327.21%334K
-2.54%230K
-57.66%141K
-12.30%214K
321.52%666K
-151.22%-147K
-24.84%236K
93.60%333K
139.67%244K
Income before tax
30.86%-23.49M
57.37%-3.34M
50.39%-4.93M
4.36%-6.73M
7.33%-8.48M
-31.73%-33.97M
3.67%-7.84M
-47.24%-9.94M
-48.98%-7.04M
-48.27%-9.15M
Income tax
Net income
30.86%-23.49M
57.37%-3.34M
50.39%-4.93M
4.36%-6.73M
7.33%-8.48M
-31.73%-33.97M
3.67%-7.84M
-47.24%-9.94M
-48.98%-7.04M
-48.27%-9.15M
Net income continuous Operations
30.86%-23.49M
57.37%-3.34M
50.39%-4.93M
4.36%-6.73M
7.33%-8.48M
-31.73%-33.97M
3.67%-7.84M
-47.24%-9.94M
-48.98%-7.04M
-48.27%-9.15M
Minority interest income
Net income attributable to the parent company
30.86%-23.49M
57.37%-3.34M
50.39%-4.93M
4.36%-6.73M
7.33%-8.48M
-31.73%-33.97M
3.67%-7.84M
-47.24%-9.94M
-48.98%-7.04M
-48.27%-9.15M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
30.86%-23.49M
57.37%-3.34M
50.39%-4.93M
4.36%-6.73M
7.33%-8.48M
-31.73%-33.97M
3.67%-7.84M
-47.24%-9.94M
-48.98%-7.04M
-48.27%-9.15M
Basic earnings per share
62.79%-0.32
88.24%-0.02
76.00%-0.06
38.89%-0.11
48.15%-0.14
0.00%-0.86
37.04%-0.17
-13.64%-0.25
-12.50%-0.18
-28.57%-0.27
Diluted earnings per share
62.79%-0.32
88.24%-0.02
76.00%-0.06
38.89%-0.11
48.15%-0.14
0.00%-0.86
37.04%-0.17
-13.64%-0.25
-12.50%-0.18
-28.57%-0.27
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -29.13%24.39M-52.25%3.67M-49.26%5.16M-6.72%6.87M-5.45%8.69M32.79%34.42M-8.66%7.69M44.03%10.17M50.59%7.37M65.68%9.19M
Selling and administrative expenses -13.65%10.61M-1.75%2.52M-15.27%2.6M-19.48%2.5M-15.78%2.99M-9.15%12.29M-28.42%2.57M-0.16%3.07M-6.60%3.1M0.17%3.55M
-General and administrative expense -13.65%10.61M-1.75%2.52M-15.27%2.6M-19.48%2.5M-15.78%2.99M-9.15%12.29M-28.42%2.57M-0.16%3.07M-6.60%3.1M0.17%3.55M
Research and development costs -10.77%37.19M36.71%11.15M-66.88%3.77M-0.83%11.48M2.21%10.79M12.04%41.68M-29.71%8.15M-2.37%11.39M36.25%11.58M94.35%10.55M
Other operating expenses -19.73%-23.41M-229.67%-10M71.70%-1.22M2.80%-7.11M-3.54%-5.09M21.19%-19.55M55.20%-3.03M44.13%-4.29M-5.57%-7.31M-43.37%-4.91M
Operating profit 29.13%-24.39M52.25%-3.67M49.26%-5.16M6.72%-6.87M5.45%-8.69M-32.79%-34.42M8.66%-7.69M-44.03%-10.17M-50.59%-7.37M-65.68%-9.19M
Net non-operating interest income expense 48.00%-13K0.00%-5K057.14%-3K50.00%-5K7.41%-25K44.44%-5K-50.00%-3K-16.67%-7K0.00%-10K
Non-operating interest expense -48.00%13K0.00%5K--0-57.14%3K-50.00%5K-7.41%25K-44.44%5K50.00%3K16.67%7K0.00%10K
Other net income (expense) 95.12%919K327.21%334K-2.54%230K-57.66%141K336.73%214K198.10%471K-151.22%-147K-24.84%236K93.60%333K107.97%49K
Special income (charges) --0--0--0--0--0---195K--0--0--0---195K
-Gain on sale of business --0--0--0--0--0---195K--0--0--0---195K
Other non- operating income (expenses) 37.99%919K327.21%334K-2.54%230K-57.66%141K-12.30%214K321.52%666K-151.22%-147K-24.84%236K93.60%333K139.67%244K
Income before tax 30.86%-23.49M57.37%-3.34M50.39%-4.93M4.36%-6.73M7.33%-8.48M-31.73%-33.97M3.67%-7.84M-47.24%-9.94M-48.98%-7.04M-48.27%-9.15M
Income tax
Net income 30.86%-23.49M57.37%-3.34M50.39%-4.93M4.36%-6.73M7.33%-8.48M-31.73%-33.97M3.67%-7.84M-47.24%-9.94M-48.98%-7.04M-48.27%-9.15M
Net income continuous Operations 30.86%-23.49M57.37%-3.34M50.39%-4.93M4.36%-6.73M7.33%-8.48M-31.73%-33.97M3.67%-7.84M-47.24%-9.94M-48.98%-7.04M-48.27%-9.15M
Minority interest income
Net income attributable to the parent company 30.86%-23.49M57.37%-3.34M50.39%-4.93M4.36%-6.73M7.33%-8.48M-31.73%-33.97M3.67%-7.84M-47.24%-9.94M-48.98%-7.04M-48.27%-9.15M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 30.86%-23.49M57.37%-3.34M50.39%-4.93M4.36%-6.73M7.33%-8.48M-31.73%-33.97M3.67%-7.84M-47.24%-9.94M-48.98%-7.04M-48.27%-9.15M
Basic earnings per share 62.79%-0.3288.24%-0.0276.00%-0.0638.89%-0.1148.15%-0.140.00%-0.8637.04%-0.17-13.64%-0.25-12.50%-0.18-28.57%-0.27
Diluted earnings per share 62.79%-0.3288.24%-0.0276.00%-0.0638.89%-0.1148.15%-0.140.00%-0.8637.04%-0.17-13.64%-0.25-12.50%-0.18-28.57%-0.27
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.09%
Sample Name
Sample Code
 +3.93%
Sample Name
Sample Code
 +2.06%
4
United States Oil Fund LP
USO
-1.12%
5
United States Gasoline Fund Lp
UGA
-2.10%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +22.28%
Sample Name
Sample Code
 +20.52%
Sample Name
Sample Code
 +19.71%
4
Zai Lab
ZLAB
+16.97%
5
Legend Biotech
LEGN
+16.57%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! Iran's foreign minister, based on the Lebanon ceasefire agreement, announced the compl Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -